Stock-based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Weighted Average Assumptions of Stock Options |
The following table sets forth the weighted-average assumptions used at the respective grant dates to determine the fair values of the Company’s stock option awards granted during the years ended December 31, 2024, 2023 and 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
|
2022 |
|
Risk-free interest rate |
|
|
4.45 |
% |
|
|
4.18 |
% |
|
|
1.61 |
% |
Expected term (years) |
|
|
6.00 |
|
|
|
6.00 |
|
|
|
6.00 |
|
Volatility |
|
|
49.02 |
% |
|
|
55.63 |
% |
|
|
56.71 |
% |
Dividend yield |
|
|
3.64 |
% |
|
|
2.87 |
% |
|
|
3.85 |
% |
Fair value per stock option |
|
$ |
10.28 |
|
|
$ |
15.36 |
|
|
$ |
9.89 |
|
The following table sets forth the assumptions used at the grant date to determine the fair value of the Company's performance stock option awards granted during the years ended December 31, 2024 and 2023.
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2024 |
|
|
2023 |
|
Risk-free interest rate |
|
|
4.43 |
% |
|
|
4.13 |
% |
Expected term (years) |
|
|
6.09 |
|
|
|
7.00 |
|
Volatility |
|
|
48.91 |
% |
|
|
56.32 |
% |
Dividend yield |
|
|
3.64 |
% |
|
|
2.87 |
% |
Fair value per performance stock option (1) |
|
$ |
10.05 |
|
|
$ |
14.97 |
|
(1)Represents the weighted-average fair value at each point of projected exercise under the Monte Carlo valuation method.
|
| Schedule of Stock Options Activity |
The following table sets forth Chemours’ stock option activity for the years ended December 31, 2024, 2023 and 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
(in Thousands) |
|
|
Weighted-average Exercise Price
(per Share) |
|
|
Weighted-average
Remaining Contractual Term (in Years) |
|
|
Aggregate
Intrinsic Value
(in Thousands) |
|
Outstanding, December 31, 2021 |
|
|
6,967 |
|
|
$ |
20.32 |
|
|
|
6.60 |
|
|
$ |
101,261 |
|
Granted |
|
|
1,031 |
|
|
|
25.98 |
|
|
|
|
|
|
|
Exercised |
|
|
(3,041 |
) |
|
|
16.76 |
|
|
|
|
|
|
|
Forfeited |
|
|
(202 |
) |
|
|
21.29 |
|
|
|
|
|
|
|
Expired |
|
|
(87 |
) |
|
|
32.78 |
|
|
|
|
|
|
|
Outstanding, December 31, 2022 |
|
|
4,668 |
|
|
$ |
23.61 |
|
|
|
7.08 |
|
|
$ |
42,668 |
|
Granted |
|
|
560 |
|
|
|
34.82 |
|
|
|
|
|
|
|
Exercised |
|
|
(1,153 |
) |
|
|
16.84 |
|
|
|
|
|
|
|
Forfeited |
|
|
(296 |
) |
|
|
29.04 |
|
|
|
|
|
|
|
Expired |
|
|
(169 |
) |
|
|
39.02 |
|
|
|
|
|
|
|
Outstanding, December 31, 2023 |
|
|
3,610 |
|
|
$ |
26.35 |
|
|
|
6.51 |
|
|
$ |
27,760 |
|
Granted |
|
|
705 |
|
|
|
27.50 |
|
|
|
|
|
|
|
Exercised |
|
|
(453 |
) |
|
|
18.23 |
|
|
|
|
|
|
|
Forfeited |
|
|
(290 |
) |
|
|
30.01 |
|
|
|
|
|
|
|
Expired |
|
|
(267 |
) |
|
|
40.04 |
|
|
|
|
|
|
|
Outstanding, December 31, 2024 |
|
|
3,305 |
|
|
$ |
26.28 |
|
|
|
6.22 |
|
|
$ |
3,294 |
|
Exercisable, December 31, 2024 |
|
|
2,319 |
|
|
$ |
25.27 |
|
|
|
5.12 |
|
|
$ |
3,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
(in Thousands) |
|
|
Weighted-average Exercise Price
(per Share) |
|
|
Weighted-average
Remaining Contractual Term (in Years) |
|
|
Aggregate
Intrinsic Value
(in Thousands) |
|
Outstanding, December 31, 2022 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Granted |
|
|
239 |
|
|
|
38.32 |
|
|
|
|
|
|
|
Vested |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Forfeited |
|
|
(64 |
) |
|
|
38.32 |
|
|
|
|
|
|
|
Expired |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Outstanding, December 31, 2023 |
|
|
175 |
|
|
$ |
38.32 |
|
|
|
9.17 |
|
|
$ |
— |
|
Granted |
|
|
204 |
|
|
|
30.25 |
|
|
|
|
|
|
|
Vested |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Forfeited |
|
|
(97 |
) |
|
|
37.27 |
|
|
|
|
|
|
|
Expired |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Outstanding, December 31, 2024 |
|
|
282 |
|
|
$ |
32.85 |
|
|
|
8.97 |
|
|
$ |
— |
|
Exercisable, December 31, 2024 |
|
|
57 |
|
|
$ |
38.32 |
|
|
|
8.17 |
|
|
$ |
— |
|
|
| Schedule of Restricted Stock Units Activity |
The following table sets forth non-vested RSUs at December 31, 2024, 2023 and 2022.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
(in Thousands) |
|
|
Weighted-average
Grant Date
Fair Value
(per Share) |
|
Non-vested, December 31, 2021 |
|
|
1,159 |
|
|
$ |
22.20 |
|
Granted |
|
|
388 |
|
|
|
28.08 |
|
Vested |
|
|
(473 |
) |
|
|
20.97 |
|
Forfeited |
|
|
(77 |
) |
|
|
21.75 |
|
Non-vested, December 31, 2022 |
|
|
997 |
|
|
$ |
25.10 |
|
Granted |
|
|
497 |
|
|
|
33.22 |
|
Vested |
|
|
(391 |
) |
|
|
20.71 |
|
Forfeited |
|
|
(236 |
) |
|
|
18.84 |
|
Non-vested, December 31, 2023 |
|
|
867 |
|
|
$ |
30.86 |
|
Granted |
|
|
430 |
|
|
|
25.02 |
|
Vested |
|
|
(343 |
) |
|
|
28.65 |
|
Forfeited |
|
|
(152 |
) |
|
|
32.50 |
|
Non-vested, December 31, 2024 |
|
|
802 |
|
|
$ |
28.36 |
|
|
| Schedule of Performance Share Units Activity |
The following table sets forth non-vested PSUs at 100% of target amounts at December 31, 2024, 2023 and 2022.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares
(in Thousands) |
|
|
Weighted-average
Grant Date
Fair Value
(per Share) |
|
Non-vested, December 31, 2021 |
|
|
755 |
|
|
$ |
26.72 |
|
Granted |
|
|
316 |
|
|
|
28.77 |
|
Vested |
|
|
(213 |
) |
|
|
43.83 |
|
Forfeited |
|
|
— |
|
|
|
— |
|
Non-vested, December 31, 2022 |
|
|
858 |
|
|
$ |
22.48 |
|
Granted |
|
|
103 |
|
|
|
40.64 |
|
Vested |
|
|
(410 |
) |
|
|
17.14 |
|
Forfeited |
|
|
(158 |
) |
|
|
30.63 |
|
Non-vested, December 31, 2023 |
|
|
393 |
|
|
$ |
31.41 |
|
Granted |
|
|
73 |
|
|
|
32.77 |
|
Vested |
|
|
(103 |
) |
|
|
26.68 |
|
Forfeited |
|
|
(272 |
) |
|
|
32.84 |
|
Non-vested, December 31, 2024 |
|
|
91 |
|
|
$ |
33.57 |
|
|